Pasithea Therapeutics (KTTA) Other Gross PP&E Adjustments (2021 - 2024)
Historic Other Gross PP&E Adjustments for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $7155.0.
- Pasithea Therapeutics' Other Gross PP&E Adjustments rose 10192.7% to $7155.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $7155.0, marking a year-over-year increase of 10192.7%. This contributed to the annual value of -$344575.0 for FY2023, which is 1104.8% up from last year.
- Pasithea Therapeutics' Other Gross PP&E Adjustments amounted to $7155.0 in Q3 2024, which was up 10192.7% from -$150386.0 recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Other Gross PP&E Adjustments registered a high of $7155.0 during Q3 2024, and its lowest value of -$184.2 million during Q1 2023.
- Its 4-year average for Other Gross PP&E Adjustments is -$19.0 million, with a median of -$387372.0 in 2022.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 231.32% in 2023, then skyrocketed by 10192.7% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Other Gross PP&E Adjustments stood at -$21.5 million in 2021, then soared by 98.2% to -$387372.0 in 2022, then increased by 11.05% to -$344575.0 in 2023, then skyrocketed by 102.08% to $7155.0 in 2024.
- Its last three reported values are $7155.0 in Q3 2024, -$150386.0 for Q2 2024, and -$339953.0 during Q1 2024.